4//SEC Filing
TRAVERSA SERGIO 4
Accession 0001213900-25-121974
CIK 0001553643other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:30 AM ET
Size
7.7 KB
Accession
0001213900-25-121974
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-12-15$4.12/sh+27,500$113,300→ 1,300,000 total - Award
Stock Appreciation Rights
2025-12-12+1,198,000→ 1,198,000 totalExercise: $4.06From: 2026-03-12Exp: 2035-12-12→ Common Stock (1,198,000 underlying)
Footnotes (3)
- [F1]The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- [F2]Purchase prices range from $4.10 to $4.12 per share, inclusive.
- [F3]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001565832
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:30 AM ET
- Size
- 7.7 KB